EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com